SARS-CoV-2 neutralizing antibodies after one or two doses of Comirnaty (BNT162b2, BioNTech/Pfizer): Kinetics and comparison with chemiluminescent assays
Andrea Padoan, Chiara Cosma, Francesco Bonfante, Foscarina Della Rocca, Francesco Barbaro, Claudia Santarossa, Luigi Dall’Olmo, Matteo Pagliari, Alessio Bortolami, Anna Maria Cattelan, Vito Cianci, Daniela Basso, Mario Plebani
Topics & Concepts
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ChemiluminescenceVirologyAntibodyCoronavirus disease 2019 (COVID-19)MedicineChemistryImmunologyInternal medicineChromatographyInfectious disease (medical specialty)DiseaseSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testing